CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
1.0700
11-2月-25 15:45:00
15 分の遅延
株式
-0.0200
-1.83%
本日の幅
1.0281 - 1.1000
ISIN
N/A
ソース
NASDAQ
-
Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board
11 7 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
27 6 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
12 6 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
09 5 2024 15:05:01 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference
08 5 2024 15:15:00 提供 Nasdaq GlobeNewswire
-
30 4 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
16 4 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
02 4 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
18 3 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
12 3 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
12 3 2024 08:45:16 提供 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
11 3 2024 11:16:48 提供 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
08 3 2024 08:45:23 提供 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
07 3 2024 08:45:03 提供 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
06 3 2024 11:23:17 提供 NetDania Notify
-
29 2 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
07 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
14 12 2023 06:05:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
13 11 2023 15:05:00 提供 Nasdaq GlobeNewswire